FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ranbaxy Atorvastatin Calcium Tablets Recall

Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured…

Ranbaxy Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Mar 5, 2014
Recall ID
D-1086-2014
Check your lot numberHow we source this data

Summary

Ranbaxy recalled Atorvastatin Calcium Tablets starting Jan 16, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1086-2014 on Mar 5, 2014. Reason: Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.

Product description

Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257 USA; by: Ranbaxy Laboratories Ltd., New Delhi -110 019, India; NDC 63304-827-90

Lot numbers, UPCs & expiration codes

2407255, 2407256 Exp. 05/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1086-2014
Classification
Class II
Status
Terminated
Recall initiated
Jan 16, 2014
FDA report date
Mar 5, 2014
Quantity
64,626 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ranbaxy Inc.

Original FDA data

Every field from FDA enforcement report D-1086-2014, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
67485
Address
600 College Rd E Ste 2100
Code information
2407255, 2407256 Exp. 05/14
Postal code
08540-6636
Report date
Mar 5, 2014
Product type
Drugs
Recall number
D-1086-2014
Classification
Class II
Recalling firm
Ranbaxy Inc.
Product quantity
64,626 bottles
Termination date
Jan 14, 2015
Reason for recall
Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257 USA; by: Ranbaxy Laboratories Ltd., New Delhi -110 019, India; NDC 63304-827-90
Distribution pattern
Nationwide
Recall initiation date
Jan 16, 2014
Initial firm notification
Letter
Center classification date
Feb 21, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1086-2014, published Mar 5, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls